Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,954 public trials 1,253 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Recruiting

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

NCT07525206

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Astera Cancer Care /ID# 279532 East Brunswick, New Jersey, United States
  • Northwell Health Center for Advanced Medicine. /ID# 279590 Lake Success, New York, United States
  • Compass Oncology - Rose Quarter /ID# 280127 Portland, Oregon, United States
  • University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 281451 Seattle, Washington, United States
View all 32 locations
View Trial Details
Recruiting

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

NCT07066657

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +18 more
Locations
  • ULCA Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
View all 21 locations
View Trial Details
Recruiting

Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement

NCT07104604

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Shantou University Medical College Cancer Hospital Shantou, Guangdong, China
  • The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China
View Trial Details
Recruiting

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

NCT07549412

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Rocky Mountain Cancer Centers, LLP- Aurora Lone Tree, Colorado, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
  • Illinois CancerCare PC Peoria, Illinois, United States
  • Springfield Clinic Springfield, Illinois, United States
View all 21 locations
View Trial Details
Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

NCT06997497

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +12 more
Locations
  • Los Angeles Hematology Oncology Medical Group ( Site 0084) Los Angeles, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0088) Santa Monica, California, United States
  • University of Colorado Health - Harmony-Cancer Care and Hematology - Ft. Collins ( Site 0087) Fort Collins, Colorado, United States
  • Rocky Mountain Cancer Centers (RMCC) ( Site 8000) Lone Tree, Colorado, United States
View all 217 locations
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

NCT06974110

Conditions
Advanced Solid Tumor, Colonic Diseases, Colorectal Cancer, +31 more
Locations
  • Investigative Site #132 Phoenix, Arizona, United States
  • Investigative Site #101 San Diego, California, United States
  • Investigative Site #128 Tampa, Florida, United States
  • Investigative Site #120 Detroit, Michigan, United States
View all 15 locations
View Trial Details

Related conditions